Cargando…
Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease
BACKGROUND: The main protease (Mpro) is a crucial target for severe acute respiratory syndrome coronavirus (SARS-CoV-2). Chitooligosaccharide (CS) has broad-spectrum antiviral activity and can effectively inhibit the activity of SARS-CoV. Here, based on the high homology between SARS-CoV-2 and SARS-...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935244/ https://www.ncbi.nlm.nih.gov/pubmed/36797775 http://dx.doi.org/10.1186/s40824-023-00351-4 |
_version_ | 1784890010723418112 |
---|---|
author | Wang, Qian Song, Yuanyuan Kim, Mungu Hahn, Sei Kwang Jiang, Ge |
author_facet | Wang, Qian Song, Yuanyuan Kim, Mungu Hahn, Sei Kwang Jiang, Ge |
author_sort | Wang, Qian |
collection | PubMed |
description | BACKGROUND: The main protease (Mpro) is a crucial target for severe acute respiratory syndrome coronavirus (SARS-CoV-2). Chitooligosaccharide (CS) has broad-spectrum antiviral activity and can effectively inhibit the activity of SARS-CoV. Here, based on the high homology between SARS-CoV-2 and SARS-CoV, this study explores the effect and mechanism of CS with various molecular weights on the activity of SARS-CoV-2 Mpro. METHODS: We used fluorescence resonance energy transfer (FRET), UV–Vis, synchronous fluorescence spectroscopy, circular dichroism (CD) spectroscopy and computational simulation to investigate the molecular interaction and the interaction mechanism between CS and SARS-CoV-2 Mpro. RESULTS: Four kinds of CS with different molecular weights significantly inhibited the activity of Mpro by combining the hydrogen bonding and the salt bridge interaction to form a stable complex. Glu166 appeared to be the key amino acid. Among them, chitosan showed the highest inhibition effect on Mpro enzyme activity and the greatest impact on the spatial structure of protein. Chitosan would be one of the most potential anti-viral compounds. CONCLUSION: This study provides the theoretical basis to develop targeted Mpro inhibitors for the screening and application of anti-novel coronavirus drugs. |
format | Online Article Text |
id | pubmed-9935244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-99352442023-02-17 Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease Wang, Qian Song, Yuanyuan Kim, Mungu Hahn, Sei Kwang Jiang, Ge Biomater Res Research Article BACKGROUND: The main protease (Mpro) is a crucial target for severe acute respiratory syndrome coronavirus (SARS-CoV-2). Chitooligosaccharide (CS) has broad-spectrum antiviral activity and can effectively inhibit the activity of SARS-CoV. Here, based on the high homology between SARS-CoV-2 and SARS-CoV, this study explores the effect and mechanism of CS with various molecular weights on the activity of SARS-CoV-2 Mpro. METHODS: We used fluorescence resonance energy transfer (FRET), UV–Vis, synchronous fluorescence spectroscopy, circular dichroism (CD) spectroscopy and computational simulation to investigate the molecular interaction and the interaction mechanism between CS and SARS-CoV-2 Mpro. RESULTS: Four kinds of CS with different molecular weights significantly inhibited the activity of Mpro by combining the hydrogen bonding and the salt bridge interaction to form a stable complex. Glu166 appeared to be the key amino acid. Among them, chitosan showed the highest inhibition effect on Mpro enzyme activity and the greatest impact on the spatial structure of protein. Chitosan would be one of the most potential anti-viral compounds. CONCLUSION: This study provides the theoretical basis to develop targeted Mpro inhibitors for the screening and application of anti-novel coronavirus drugs. BioMed Central 2023-02-17 /pmc/articles/PMC9935244/ /pubmed/36797775 http://dx.doi.org/10.1186/s40824-023-00351-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Wang, Qian Song, Yuanyuan Kim, Mungu Hahn, Sei Kwang Jiang, Ge Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease |
title | Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease |
title_full | Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease |
title_fullStr | Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease |
title_full_unstemmed | Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease |
title_short | Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease |
title_sort | effect of chitooligosaccharide on the inhibition of sars-cov-2 main protease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935244/ https://www.ncbi.nlm.nih.gov/pubmed/36797775 http://dx.doi.org/10.1186/s40824-023-00351-4 |
work_keys_str_mv | AT wangqian effectofchitooligosaccharideontheinhibitionofsarscov2mainprotease AT songyuanyuan effectofchitooligosaccharideontheinhibitionofsarscov2mainprotease AT kimmungu effectofchitooligosaccharideontheinhibitionofsarscov2mainprotease AT hahnseikwang effectofchitooligosaccharideontheinhibitionofsarscov2mainprotease AT jiangge effectofchitooligosaccharideontheinhibitionofsarscov2mainprotease |